900000000000530003: referentieset voor associaties betreffende alternatieve concepten (metadata)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\ALTERNATIVE association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
ALTERNATIVE association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Product containing hydralazine and isosorbide	Product containing hydralazine and isosorbide dinitrate (medicinal product)
Product containing hydralazine and isosorbide in oral dose form (medicinal product form)	Hydralazine- and isosorbide dinitrate-containing product in oral dose form
Product containing hydroxyquinoline and antiprotozoal	Antiprotozoal
Product containing hydroxyquinoline and antiprotozoal	Oxyquinoline
Product containing isosorbide in oromucosal dose form (medicinal product form)	Isosorbide dinitrate-containing product in oromucosal dose form
Product containing isosorbide in oropharyngeal dose form (medicinal product form)	Isosorbide dinitrate-containing product in oromucosal dose form
Product containing isosorbide in parenteral dose form (medicinal product form)	Isosorbide dinitrate-containing product in parenteral dose form
Product containing isosorbide in sublingual dose form (medicinal product form)	Isosorbide dinitrate-containing product in oromucosal dose form
Product containing isosorbide in transdermal dose form (medicinal product form)	Isosorbide dinitrate-containing product in transdermal dose form
Product containing only aspirin and isosorbide (medicinal product)	Aspirin and isosorbide mononitrate only product
Product containing only blood group antibody D (medicinal product)	Product containing only human anti-D immunoglobulin in parenteral dose form (medicinal product form)
Product containing only blood group antibody D in parenteral dose form (medicinal product form)	Product containing only human anti-D immunoglobulin in parenteral dose form (medicinal product form)
Product containing only collodion (medicinal product)	Collodion
Product containing only hydralazine and isosorbide (medicinal product)	Product containing only hydralazine and isosorbide dinitrate (medicinal product)
Product containing only hydralazine and isosorbide in oral dose form (medicinal product form)	Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form)
Product containing only isosorbide in oromucosal dose form (medicinal product form)	Isosorbide dinitrate only product in oromucosal dose form
Product containing only isosorbide in parenteral dose form (medicinal product form)	Isosorbide dinitrate only product in parenteral dose form
Product containing only isosorbide in transdermal dose form (medicinal product form)	Isosorbide dinitrate only product in transdermal dose form
Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 10 milligram/1 each conventional release oral tablet	Amitriptyline (as amitriptyline hydrochloride) 12.5 mg and chlordiazepoxide 10 mg oral tablet
Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet	Product containing precisely amitriptyline (as amitriptyline hydrochloride) 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely blood group antibody D 1136 unit/1 milliliter conventional release solution for injection (clinical drug)	Product containing precisely human anti-D immunoglobulin 1136.364 unit/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection (clinical drug)	Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection ampule	Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug)	Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection ampule	Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely methylergometrine maleate 20 microgram/1 each conventional release oral tablet	Product containing precisely methylergometrine maleate 200 microgram/1 each conventional release oral tablet (clinical drug)
Product containing precisely phenol 1.25 gram/25 milliliter prolonged-release oil for injection vial	Phenol 50 mg/mL solution for injection
Product containing precisely phenol 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug)	Phenol 50 mg/mL solution for injection
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection	Product containing precisely triptorelin (as triptorelin pamoate) 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug)
Prolonged-release oil for injection	Prolonged-release solution for injection (dose form)
Prolonged-release oil for injection	Solution for injection
Prostatic	Prostatic structure
Psychiatric function	Mental function (observable entity)
Psychiatric function	Psychological function
Psychostimulant poisoning NOS	Psychostimulant overdose
Pulmonary	Pulmonary structure including vessels and lymphoid tissue
Purine diuretic poisoning NOS	Adverse reaction to purine derivative diuretic
Quinagolide 25micrograms tablet and 50micrograms tablet starter	Product containing precisely quinagolide (as quinagolide hydrochloride) 25 microgram/1 each conventional release oral tablet (clinical drug)
Quinagolide 25micrograms tablet and 50micrograms tablet starter	Quinagolide (as quinagolide hydrochloride) 50 microgram oral tablet
Radial	Bone structure of radius (body structure)
Radiographic procedure on upper extremity AND/OR shoulder	Plain X-ray of upper limb (procedure)
Radiographic procedure on upper extremity AND/OR shoulder	Plain X-ray of shoulder
Radiology not requested	Plain X-ray not requested (situation)
Radionuclide ectopic gastric mucosa study	Radionuclide imaging of small intestine for Meckel diverticulum (procedure)
Radionuclide ectopic gastric mucosa study	Bowel imaging for Meckel's diverticulum
Radionuclide ectopic gastric mucosa study	Radionuclide small intestine study
Rectal	Rectum structure
Respiratory site descriptor	Structure of respiratory system (body structure)
Respiratory symptoms	Disorder of respiratory system (disorder)
Respiratory symptoms	Respiratory finding
Respiratory tract intervention	Procedure on respiratory system
Respiratory tract intervention	Imaging guidance
Retroperitoneal fistulogram	Fluoroscopy of fistula of retroperitoneum with contrast
Retroperitoneal fistulogram	CT of fistula of retroperitoneum with contrast
Retroperitoneal fistulography	Fluoroscopy of fistula of retroperitoneum with contrast
Retroperitoneal fistulography	CT of fistula of retroperitoneum with contrast
Ropinirole 0.5mg+1mg+2mg tablet follow-on pack	Ropinirole (as ropinirole hydrochloride) 1 mg oral tablet
Ropinirole 0.5mg+1mg+2mg tablet follow-on pack	Ropinirole (as ropinirole hydrochloride) 500 microgram oral tablet
Ropinirole 0.5mg+1mg+2mg tablet follow-on pack	Ropinirole (as ropinirole hydrochloride) 2 mg oral tablet
Ropinirole 250micrograms+500micrograms+1000micrograms tablet starter pack	Ropinirole (as ropinirole hydrochloride) 1 mg oral tablet
Ropinirole 250micrograms+500micrograms+1000micrograms tablet starter pack	Product containing precisely ropinirole (as ropinirole hydrochloride) 250 microgram/1 each conventional release oral tablet (clinical drug)
Ropinirole 250micrograms+500micrograms+1000micrograms tablet starter pack	Ropinirole (as ropinirole hydrochloride) 500 microgram oral tablet
Rubella antib. present -immune	Immunity to rubella determined by serology
Rubella antib. present -immune	Rubella antibody detected (finding)
Sacroiliac	Sacroiliac joint structure
Salivary	Salivary structure
Salpingography	Selective salpingography using fluoroscopic guidance (procedure)
Salpingography	Fluoroscopic hysterosalpingography with contrast (procedure)
Saluretic poisoning NOS	Adverse reaction to saluretic agent
Scrotal	Scrotal structure
Sexual symptom	Sexual disorder
Sexual symptom	Finding relating to sexuality and sexual activity
Sexual symptom	Finding of sexual function
Sinusoidal	Sinus (morphologic abnormality)
Skeletal X-ray	Plain X-ray of bone
Skeletal X-ray	Plain X-ray skeletal survey
Skeletal X-ray	Plain X-ray of skeletal system
Skeletal site descriptor	Skeletal system structure
Skin symptoms	Disorder of skin (disorder)
Skin symptoms	Skin finding
Skin symptoms	Skin finding
Skin symptoms	Skin finding
Skin symptoms	Disorder of skin (disorder)
Skin symptoms	Disorder of skin (disorder)
Small intestinal intervention	Imaging guidance
Small intestinal intervention	Procedure on small intestine
Snoring symptoms	Snoring
Snoring symptoms	Habitual snoring (finding)
Social problem	Social context finding
Social problem	Social and personal history finding
Soft tissue X-ray of shoulder and upper limb	Plain X-ray of soft tissue of shoulder (procedure)
Soft tissue X-ray of shoulder and upper limb	Plain X-ray of soft tissue of upper limb
Soft tissue graft or flap or repair failure	Disorder following grafting procedure (disorder)
Specimen measurable	Specimen observable (observable entity)
Sphenoidal	Sphenoid bone structure
Splenography	CT of spleen
Splenography	Ultrasonography of spleen with contrast (procedure)
Splenography	Spleen imaging
Splenography	Computed tomography of spleen with contrast (procedure)
Splenography	US scan of spleen
Splenography	Plain X-ray of spleen

Start Previous Page 9 of 29 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001164016	ALTERNATIVE association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001165015	ALTERNATIVE association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
8155831000146119	referentieset voor alternatieve associaties	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)
9038761000146119	referentieset voor associaties betreffende alternatieve concepten	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)
14125721000146114	referentieset voor associaties betreffende alternatieve concepten (metadata)	nl	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)